Affiliations: [a]
School of Healthcare Sciences, Cardiff University, Cardiff, United Kingdom
| [b] Division of Physical Therapy, College of Medicine, The Ohio State University, Columbus, OH, USA
Correspondence:
[*]
Correspondence to: Una Jones, School of Healthcare Sciences, Cardiff University, Cardiff CF14 4XN. United Kingdom. Tel.: 00443920687789; E-mail: [email protected].
Abstract: Background:The recently published clinical practice guideline for physiotherapy practice for Huntington’s disease (HD) should be integrated into practice to develop interventions that enable people with HD to achieve personalised goals. The European Huntington’s Disease Network Physiotherapy Working Group aims to support and enable the use of best evidence in physiotherapy for the HD community. Successful implementation of the clinical practice guidelines requires an understanding of facilitators and barriers to therapist implementation. Objective:To explore facilitators and barriers to implementing recently published clinical recommendations that guide physiotherapy practice for HD. Methods:An online survey was distributed globally through HD networks. Data collected included demographic information and agreement/disagreement with a series of named facilitators and barriers to implementation of each of the six physiotherapy guideline recommendations. A consensus level of≥70% agreement was set as indicative of agreement/disagreement. Results:Thirty-two physiotherapists working in a range of settings responded. Support from colleagues (81–91% agreement), an individualised physiotherapy plan (72–88% agreement) and physiotherapist’s expertise in HD (81–91% agreement) were reported as facilitators. The main barriers were behavioural (72–81% agreement) and cognitive (75–81% agreement) impairments and low motivation (72–78% agreement) in persons with HD. Conclusion:Physiotherapists agree that their expertise in HD and support from colleagues facilitate the development of individualised treatment plans. Further work needs to develop creative ways in which barriers specific to the cognitive and behavioural aspects of HD can be managed to enable treatment plans to be implemented.
